RU2002117537A - A method for treating the effects of tissue hypoxia in critically ill patients - Google Patents
A method for treating the effects of tissue hypoxia in critically ill patientsInfo
- Publication number
- RU2002117537A RU2002117537A RU2002117537/14A RU2002117537A RU2002117537A RU 2002117537 A RU2002117537 A RU 2002117537A RU 2002117537/14 A RU2002117537/14 A RU 2002117537/14A RU 2002117537 A RU2002117537 A RU 2002117537A RU 2002117537 A RU2002117537 A RU 2002117537A
- Authority
- RU
- Russia
- Prior art keywords
- treating
- effects
- critically ill
- ill patients
- tissue hypoxia
- Prior art date
Links
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2002117537/14A RU2226096C1 (en) | 2002-07-01 | 2002-07-01 | Method for treating hypoxia consequences in patients in critical state |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2002117537/14A RU2226096C1 (en) | 2002-07-01 | 2002-07-01 | Method for treating hypoxia consequences in patients in critical state |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002117537A true RU2002117537A (en) | 2004-02-10 |
RU2226096C1 RU2226096C1 (en) | 2004-03-27 |
Family
ID=32390520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002117537/14A RU2226096C1 (en) | 2002-07-01 | 2002-07-01 | Method for treating hypoxia consequences in patients in critical state |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2226096C1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL373780A1 (en) | 2002-02-25 | 2005-09-19 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
EP1853544A4 (en) | 2005-02-24 | 2010-06-16 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
AU2008246305B2 (en) | 2007-04-13 | 2013-03-21 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
EP2445339B1 (en) | 2009-06-22 | 2019-08-07 | Diffusion Pharmaceuticals LLC | Diffusion enhancing compound and its use with a thrombolytic |
ES2654945T3 (en) | 2010-06-02 | 2018-02-15 | Diffusion Pharmaceuticals Llc | Oral formulations of trans bipolar carotenoids |
CN109152839A (en) | 2016-03-24 | 2019-01-04 | 扩散药品有限公司 | Purposes of the bipolarity trans-carotenoid together with chemotherapy and radiotherapy in treating cancer |
-
2002
- 2002-07-01 RU RU2002117537/14A patent/RU2226096C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2226096C1 (en) | 2004-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05007857A (en) | Indole-derivative modulators of steroid hormone nuclear receptors. | |
MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
AU1249902A (en) | Effective antitumour treatments | |
EA200400548A1 (en) | TREATMENT OF HEAVY PNEUMONIA THROUGH THE INTRODUCTION OF THE TISSUE FACTOR INHIBITOR (TFPI) | |
NO994165L (en) | Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness | |
NZ507203A (en) | Use of dexmedetomidine for ICU sedation | |
HK1077215A1 (en) | A pharmaceutical composition for treatment of acute myocardial infarction | |
EP1440689A3 (en) | Treatment of neurotic disorders | |
RU2002117537A (en) | A method for treating the effects of tissue hypoxia in critically ill patients | |
BR0009380A (en) | Improved cancer treatment with temozozomide | |
MD2549F1 (en) | Method of treatment of the chronic viral hepatitis C | |
FI20011464A0 (en) | Combination therapy for the treatment of heart failure | |
RU2004112422A (en) | ROUVASTATIN IN PREDEDENTIONAL CONDITIONS | |
DE60111622D1 (en) | ISOLATED DOSE THERAPIES WITH VULNERABLE ACTIVITY | |
EP1622450A4 (en) | Method for promoting uninterrupted sleep by administration of trospium chloride | |
WO2001007038A3 (en) | Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy | |
NZ542305A (en) | Treatment of proliferative diseases with an epothilone derivative and radiation | |
WO2003072019A3 (en) | Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog | |
DE60235965D1 (en) | COMBINATION OF LEVOSIMENDAN AND A CALCIUM SOURCE FOR THE TREATMENT OF HEART FAILURE | |
MD1780F1 (en) | Method of treatment of patients with hepatic cirrhosis | |
AU2003288107A1 (en) | Tiotropium-containing medicament combinations used for inhaling | |
MXPA03010920A (en) | Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia. | |
RU2003125142A (en) | METHOD OF PERFUOROAN USE | |
RU2000110690A (en) | METHOD OF ANTIBIOTIC THERAPY | |
RU2002109357A (en) | A method for the treatment of dysbiotic intestinal disorders in patients with pulmonary tuberculosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20040702 |